Provenienza dei contatti di primo grado di Robert E. Hurst
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Vuja De Sciences, Inc.
Vuja De Sciences, Inc. Pharmaceuticals: MajorHealth Technology Vuja De Sciences, Inc. is engaged in biotechnology services. The company was founded by David Warshawsky, Rick Lampe, Robert E. Hurst and Raphael Nir and is headquartered in Hoboken, NJ.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Robert E. Hurst tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Emtora Biosciences, Inc.
Emtora Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Emtora Biosciences, Inc. operates as a drug development company which focuses on disease treatment and prevention through agents that modulate the mTor pathway in mammals. It produces drugs to slow the aging process and its efficacy in treating age-related diseases. The company was founded in 2012 and is headquartered in San Antonio, TX. | Pharmaceuticals: Major | Chief Executive Officer | |
The Johns Hopkins University | College/University | Doctorate Degree | |
University of North Texas | College/University | Undergraduate Degree | |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Doctorate Degree | |
New Jersey Institute of Technology | College/University | Graduate Degree | |
SCHRÖDINGER, INC. | Packaged Software | Founder | |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Avraham Pharmaceuticals Ltd.
Avraham Pharmaceuticals Ltd. BiotechnologyHealth Technology Avraham Pharmaceuticals Ltd. develops pharmaceutical products for prevention and treatment of neurodegenerative disorders. Its lead product candidate, Ladostigil is designed to provide treatment for Mild Cognitive Impairment. The firm’s product candidate is a multifunctional compound that combines neuroprotective mechanisms: reducing oxidative stress and microglial activation, and inhibiting proinflamtory cytokines. The company was founded in 2010 by David Warshawsky and is headquartered in Yavneh, Israel. | Biotechnology | Chief Executive Officer | |
Syracuse University College of Law | College/University | Graduate Degree | |
SBH Sciences, Inc.
SBH Sciences, Inc. BiotechnologyHealth Technology SBH Sciences, Inc. offers biotechnology products and services for discovery research. The private company is based in Natick, MA. The company support startup companies, entrepreneur scientists, and the biotechnology industry to helps shorten timelines and reduce costs. The company also provides precise and reliable biomarker evaluations for veterinary and in vivo studies of rats, pigs, equines, and canines. | Biotechnology | Founder | |
Helocyte, Inc.
Helocyte, Inc. Miscellaneous Commercial ServicesCommercial Services Helocyte, Inc. engages in the development and commercialization of immunotherapies for the prevention and treatment of cytomegalovirus or CMV (cancer and infectious disease). It focuses on developing PepVax, a HLA-restricted single antigen peptide vaccine for controlling CMV in allogeneic hematopoietic stem cell transplant recipients and Triplex. The company was founded by Donald J. Diamond in 2015 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder | |
Cellvation, Inc. | Founder | ||
Sky Ventures International LLC
Sky Ventures International LLC Investment ManagersFinance Sky Ventures International LLC (Sky Ventures) is a venture capital firm founded in 2015 by Eyal Geffen and Raphael Nir. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder | |
Faxian Therapeutics LLC | Director/Board Member | ||
NeuroDex, Inc.
NeuroDex, Inc. Miscellaneous Commercial ServicesCommercial Services NeuroDex, Inc. engages in the development of a research platform focuses on diagnostics, theranostics, prognostics, and pharmacodynamic analysis. It offers ExoSORT that combines bioinformatics and state-of-the-art laboratory processes. The company was founded by Erez Eitan and Oded Biran in 2018 and is headquartered in Arlington, MA. | Miscellaneous Commercial Services | Founder | |
Alma Bio Therapeutics
Alma Bio Therapeutics Miscellaneous Commercial ServicesCommercial Services Alma Bio Therapeutics is a French company that aims to restore immune resilience in patients suffering from autoimmune diseases. The private company's therapeutic approach employs the language of the immune system to improve patients' health by targeting the underlying cause of the disease. The company's treatment aims to support the immune system rather than suppressing it, restoring its natural resilience and providing improved safety and an opportunity for durable remission. Alma Bio Therapeutics has developed a breakthrough therapy that is targeted, specific, and confined to the site of disease, reinstating immune balance with no overdrive or complete suppression. The company's platform-technology is applicable to several autoimmune diseases, promising to yield a versatile pipeline. The company's lead programs are directed towards diseases of complex etiology in areas of significant unmet clinical need, with inflammatory bowel disease (IBD) as their first clinical indication. Alma Bio Therapeutics is led by a seasoned management team with extensive expertise in business development, drug development, and technology commercialization. | Miscellaneous Commercial Services | Founder | |
Abi-Lab2 LLC | Founder |
Statistiche
Distribuzione geografica
Stati Uniti | 16 |
Israele | 3 |
Francia | 2 |
Settori
Consumer Services | 6 |
Health Technology | 5 |
Commercial Services | 5 |
Technology Services | 2 |
Finance | 2 |
Posizioni
Founder | 12 |
Director/Board Member | 10 |
Corporate Officer/Principal | 6 |
Chief Executive Officer | 5 |
President | 3 |
Contatti più connessi
Insiders | |
---|---|
Frank Taffy | 10 |
Raphael Nir | 8 |
David Warshawsky | 2 |
Carl Barrett | 2 |
Rick Lampe | 1 |
Chand Khanna | 1 |
Lee Helman | 1 |
- Borsa valori
- Insiders
- Robert E. Hurst
- Connessioni Società